2026³â 06¿ù 24ÀÏ ¼ö¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

DNP Invests in Rapidus to Support the Establishment of Mass Production for Next-Generation Semiconductors

Will accelerate the development and mass production of EUV lithography photomasks.
´º½ºÀÏÀÚ: 2026-03-26

TOKYO -- Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) announced that it has participated in Rapidus Corporation’s funding round as one of the round investors. This strategic funding initiative supports Rapidus’ plan to steadily progress from its current R&D phase to mass production of 2nm (10⁻⁹ meters) logic semiconductors by 2027.

Through this initiative, DNP will advance the development and mass production of EUV lithography photomasks and support Rapidus as it establishes a mass production system for 2nm & next-generation semiconductors.

Background


In recent years, the rise in energy consumption, in line with increased data generation, has become a challenge, driving demand for next-generation semiconductors capable of improving device performance and reducing power consumption.

Next-generation semiconductors manufactured using EUV lithography enable the formation of finer patterns on silicon wafers compared to currently available technologies. This in turn is boosting expectations for the realization of higher performance and lower power consumption semiconductors.

Against this backdrop, in 2024 DNP was selected as a subcontractor for Rapidus under the Post-5G Information and Communications System Infrastructure Enhancement R&D Project, led by the New Energy and Industrial Technology Development Organization (NEDO). Under this project, DNP has been advancing the development of manufacturing processes for 2nm generation EUV lithography photomasks.

Looking ahead, toward Rapidus’ goal of achieving mass production of 2nm-generation logic semiconductors in 2027, DNP aims to realize high-yield and short-lead-time production of EUV lithography photomasks for the 2nm generation at an early stage. Our investment will further strengthen the partnership between our two companies that has been cultivated to date.

Going Forward

DNP positions EUV lithography photomasks as a key growth driver of its semiconductor-related business. We will continue to make proactive investments while advancing technology development with a view toward even finer 1.4nm generation and beyond. Through these efforts, DNP will contribute to the growth of Japan’s semiconductor industry.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Boomi to Acquire Lunar.dev to Deliver Governed Agent Connectivity Across Enterprise
Prokarium Reports Positive Interim PARADIGM-1 Data of ZH9 in NMIBC, Showing Excellent Safety and Early Efficacy
Training Lasers Installed at Gigaphoton Kyushu Office
LTM Launches BlueVerse¢â for iRun to Outcreate Managed Services in the Agentic AI Era
IFF Secures First Heart Health Claim for Soy Protein in Australia and New Zealand
NIQ Research Reveals New Rules of Commerce: AI Is Beginning to Decide What Consumers Buy
Boomi Unveils Innovations That Power the Agentic Enterprise

 

Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Pro...
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60...
Telehouse Canada Undergoes Major Infrastructure Upgrade to Scale AI-Dr...
Enterprise AI Hits the Wall: NTT DATA Research Reveals Growing Privacy...
Experian Partners With ServiceNow to Scale Trusted Decisioning to Agen...
Boomi and Red Hat Collaborate on Production-Ready Agentic AI
Medisca and dsm-firmenich Partner to Expand Access to Pharma-Grade Vit...

 


°øÁö»çÇ×
¹Ìµð¾î¿Í M• Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë A⋮⋮⋮ Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò W⋮⋮⋮ Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï B⋮ BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ...
º£³×ÀÍ ¡Õ Beneik 宝Ò¬ìÌ, À̺ñÁî eBizh æ¶币òª EZ æ¶òª
¿¡³ÊÀÌÀ¯ ¡Õ¡Õ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ ^v Alliuv ä¹备 AV ä¹êó备, ¾Ë¶ã =^= Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º ¡ÕC À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò ^ Alfrom ä¹尔ÜØ ä¹ì³ÜØ, ¿ÃÇÁ·Ò A⋮⋮ Allfrom &...

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..